Clinical trials data
Digit Span Test in mild cognitive impairment trials: 169 registered studies
Every registered mild cognitive impairment study on ClinicalTrials.gov that names the Digit Span Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered mild cognitive impairment studies name it in an outcome measure
- 169
- Name it in a primary outcome, 46%
- 77 of 169
Tests named in the same studies
- 1
Trail Making Test95 studies, 35 as a primary outcome
- 2
Verbal Fluency67 studies, 28 as a primary outcome
- 3
Verbal Learning59 studies, 32 as a primary outcome
- 4
Category Fluency39 studies, 18 as a primary outcome
- 5
Stroop Color-Word Test39 studies, 13 as a primary outcome
- 6
Symbol Coding32 studies, 19 as a primary outcome
- 7
Short Story Recall29 studies, 14 as a primary outcome
- 8
Picture Naming Test27 studies, 9 as a primary outcome
- 9
Clock Drawing Task16 studies, 9 as a primary outcome
- 10
Complex Figure Copy and Recall11 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 1 |
| 2010 | 6 | 2 |
| 2011 | 2 | 0 |
| 2012 | 4 | 2 |
| 2013 | 2 | 0 |
| 2014 | 3 | 2 |
| 2015 | 8 | 4 |
| 2016 | 7 | 5 |
| 2017 | 6 | 3 |
| 2018 | 4 | 1 |
| 2019 | 10 | 3 |
| 2020 | 14 | 5 |
| 2021 | 15 | 10 |
| 2022 | 12 | 5 |
| 2023 | 15 | 8 |
| 2024 | 22 | 12 |
| 2025 | 19 | 7 |
| 2026 | 16 | 5 |
Phases and study sizes
By phase
- Phase 13 studies, 1 as a primary outcome
- Phase 1/22 studies, 1 as a primary outcome
- Phase 214 studies, 6 as a primary outcome
- Phase 33 studies, 2 as a primary outcome
- Phase 43 studies, 0 as a primary outcome
- Not applicable135 studies, 62 as a primary outcome
- Observational9 studies, 5 as a primary outcome
Participants per study
- Phase 286 median, 52 to 176
- Not applicable60 median, 40 to 113
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 13 | 86 | 52 to 176 |
| Not applicable | 135 | 60 | 40 to 113 |
When mild cognitive impairment trials measure it
Latest time point of each outcome
- Within a day11 outcomes, 7 as a primary outcome
- Up to 4 weeks12 outcomes, 3 as a primary outcome
- 1 to 3 months52 outcomes, 27 as a primary outcome
- 3 to 6 months35 outcomes, 18 as a primary outcome
- 6 to 12 months28 outcomes, 6 as a primary outcome
- 1 to 2 years12 outcomes, 6 as a primary outcome
- Over 2 years5 outcomes, 2 as a primary outcome
- No duration given14 outcomes, 8 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
155 of the 169 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting32 studies, 17 as a primary outcome
- Not yet recruiting16 studies, 6 as a primary outcome
- Active, not recruiting5 studies, 2 as a primary outcome
- Completed78 studies, 32 as a primary outcome
- Stopped early9 studies, 5 as a primary outcome
- Status unknown29 studies, 15 as a primary outcome
What they test
- Behavioral62 studies, 30 as a primary outcome
- Drug18 studies, 6 as a primary outcome
- Device37 studies, 15 as a primary outcome
- Dietary supplement14 studies, 6 as a primary outcome
- Procedure8 studies, 4 as a primary outcome
- Diagnostic test3 studies, 2 as a primary outcome
- Biological1 studies, 1 as a primary outcome
- Combination product3 studies, 2 as a primary outcome
- Other49 studies, 25 as a primary outcome
- None given4 studies, 2 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States43 studies, 21 as a primary outcome
- Hong Kong15 studies, 9 as a primary outcome
- China11 studies, 3 as a primary outcome
- Italy11 studies, 1 as a primary outcome
- Canada10 studies, 4 as a primary outcome
- Taiwan10 studies, 4 as a primary outcome
- Singapore9 studies, 6 as a primary outcome
- Spain7 studies, 2 as a primary outcome
- United Kingdom7 studies, 3 as a primary outcome
- Germany6 studies, 2 as a primary outcome
- Greece6 studies, 5 as a primary outcome
- Switzerland6 studies, 2 as a primary outcome
31 countries in all. A study with sites in several counts in each; 17 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed mild cognitive impairment studies that name the Digit Span Test: 34 of 78, 44%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed mild cognitive impairment studies that name the Digit Span Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 8% | 776, 10% |
| Results on ClinicalTrials.gov only | 11, 14% | 1,139, 14% |
| A results paper only | 17, 22% | 1,711, 22% |
| Neither | 44, 56% | 4,327, 54% |
The 169 studies
169 studies match. 77 name the Digit Span Test in a primary outcome. Median size 60 participants. Median time to the primary outcome: 13 weeks.
Loading 169 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 1 |
| 2010 | 6 | 2 |
| 2011 | 2 | 0 |
| 2012 | 4 | 2 |
| 2013 | 2 | 0 |
| 2014 | 3 | 2 |
| 2015 | 8 | 4 |
| 2016 | 7 | 5 |
| 2017 | 6 | 3 |
| 2018 | 4 | 1 |
| 2019 | 10 | 3 |
| 2020 | 14 | 5 |
| 2021 | 15 | 10 |
| 2022 | 12 | 5 |
| 2023 | 15 | 8 |
| 2024 | 22 | 12 |
| 2025 | 19 | 7 |
| 2026 | 16 | 5 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 13, other 156. Interventional 160, observational 9.
As a primary outcomeSecondary or other outcomeThe Digit Span Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07863518 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants61 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07799584 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07766993 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07735910 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07672977 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants30 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07656389 | Start2026 | PhaseObservational | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants192 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07652775 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07650318 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07642518 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07636538 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07598409 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Healthy volunteers, Aging, frailty and exercise | Participants156 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07517380 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07512193 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants10 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07497334 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07389655 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07385937 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07334392 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07321821 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants60 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07318038 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants20 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07241598 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
Questions, answered from the data
How many mild cognitive impairment trials use the Digit Span Test?
169 registered mild cognitive impairment studies on ClinicalTrials.gov name it in an outcome measure, 77 of them in a primary outcome: 20% of the condition's 859 studies with a cognitive outcome, against 10% of all of them. It is the 4th most named test in mild cognitive impairment trials.
Which tests do mild cognitive impairment trials use with the Digit Span Test?
The Trail Making Test (95 studies), Verbal Fluency (67 studies) and Verbal Learning (59 studies).
How many participants do phase 2 mild cognitive impairment trials that use the Digit Span Test enroll?
Half of the phase 2 studies that name it enroll 86 participants or fewer, and the middle half enroll 52 to 176. 13 of them give a size.
When do mild cognitive impairment trials measure the Digit Span Test?
Half of the primary outcomes that name the Digit Span Test are measured within 13 weeks of the start, and the middle half from 8 weeks to 6 months. 69 primary outcomes give a duration.
How many completed mild cognitive impairment trials that use the Digit Span Test have reported results?
34 of the 78 completed studies that name it, 44%, have reported results: 17 posted them on ClinicalTrials.gov, 23 have a results paper linked to the registry record, and 6 did both. The other 44 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Digit Span Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.